Skip to content

Clinical trials

Phase 3 Influenza, Human trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Influenza, Human Phase: Phase 3 Country / region: Japan Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20122
20134
20151
20161
20192
20201
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UMN Pharma Inc.4
Alachua Government Services, Inc.2
Hoffmann-La Roche2
AstraZeneca1
Daiichi Sankyo Co., Ltd.1
GlaxoSmithKline1
ModernaTX, Inc.1
Sanofi Pasteur, a Sanofi Company1
UMC Utrecht1
University of Shizuoka1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Influenza, Human15
COVID-193
Respiratory Tract Infections3
Lung Diseases2
Community-Acquired Pneumonia1
Coronavirus Infections1
Infections1
Pneumonia1
Respiratory Distress Syndrome1
Respiratory Tract Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.